Last10K.com

Advansource Biomaterials Corp (ASNB) SEC Filing 10-Q Quarterly report for the period ending Sunday, December 31, 2017

Advansource Biomaterials Corp

HISTORY TOOLS
CIK: 1011060 Ticker: ASNB
Document and Entity Information - USD ($)
9 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jan. 31, 2017
Document and Entity Information:   
Entity Registrant NameAdvansource Biomaterials Corp  
Document Type10-Q  
Document Period End DateDec. 31, 2017  
Amendment Flagfalse  
Entity Central Index Key0001011060  
Current Fiscal Year End Date--03-31  
Entity Common Stock, Shares Outstanding  21,490,621
Entity Public Float $ 1,711,466 
Entity Filer CategorySmaller Reporting Company  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Well-known Seasoned IssuerNo  
Document Fiscal Year Focus2018  
Document Fiscal Period FocusQ3  
Trading Symbolasnb  

View differences made from one quarter to another to evaluate Advansource Biomaterials Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advansource Biomaterials Corp.

Continue

Assess how Advansource Biomaterials Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advansource Biomaterials Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Advansource Biomaterials Corp provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
Ticker: ASNB
CIK: 1011060
Form Type: 10-Q Quarterly Report
Accession Number: 0001556244-18-000030
Submitted to the SEC: Wed Feb 14 2018 1:06:34 PM EST
Accepted by the SEC: Wed Feb 14 2018
Period: Sunday, December 31, 2017
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/asnb/0001556244-18-000030.htm